Clinical Implementation of a Novel Decision Support Tool in Patients With Ischemic Heart Disease
Condition(s) studied
Investigational drug(s) / intervention(s)
PM HeartIHD prediction: The calculated prediction and the explainability factors will be made available to the physician, which the physician then can decide to take into his/hers evaluation about further treatment.
Study summary
The PM-Heart algorithm (PMHeartIHD) is an in-house developed software that predict the survival prognosis for the individual patient hospitalized with ischemic heart disease (IHD) after a coronary arteriography has been performed. The software is intended to be used as a clinical decision support system i.e. the calculated survival prognosis is expected to enhance the quality of the treating physician's therapeutic considerations concerning (minor) adjustments to the patients treatment and follow-up - all within the framework of the current medical guidelines. Thus, the algorithm does not "show the physician specifically what to do", but rather ensures a better knowledgebase for the overall interpretation and choice of management of the patient.
Eligibility
Primary outcome measure(s)
- Number and duration of readmissions within one month after randomization — From randomization to the study and up to 1 year hereafter
A composite outcome of a) readmissions within one month, and 2) all-cause mortality within one year - for patients randomized to the study. All the outcomes listed below will be assessed as a comparison between the "intervention group" and the "control group". - Number and cause of death (all-cause mortality) within one year after randomization — From randomization to the study and up to 1 year hereafter
A composite outcome of a) readmissions within one month, and 2) all-cause mortality within one year - for patients randomized to the study.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Department of Cardiology, The Heart Centre, Rigshospitalet Copenhagen University Hospital. | Copenhagen Ø | Denmark | Recruiting |
More Copenhagen University Hospital, Rigshospitalet trials in Denmark
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06033014 on ClinicalTrials.gov ↗ ← All trials in Denmark